1007478-57-0
Chemical Structure
2-NP-AOZ-d4
- CAS No.: 1007478-57-0
- Formula:C10H5D4N3O4
- Molecular Weight:239.22
IUPAC Name: (E)-3-((2-nitrobenzylidene)amino)oxazolidin-2-one-4,4,5,5-d4
InChIKey: OHYXOGZWSSNLON-XMKBWRBRSA-N
SMILES: O=C1OC([2H])([2H])C([2H])([2H])N1/N=C/C2=CC=CC=C2[N+]([O-])=O
Biological Activity: 2-NP-AOZ-d4 is a deuterium labeled 2-NP-AOZ. 2-NP-AOZ is a 2-nitrophenyl derivative of AOZ (a tissue-bound metabolite of the Furazolidone). 2-NP-AOZ can be used to determination of the AOZ residues[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
2-NP-AOZ-d4 | 2-NP-AOZ-d4 is a deuterium labeled 2-NP-AOZ. 2-NP-AOZ is a 2-nitrophenyl derivative of AOZ (a tissue-bound metabolite of the Furazolidone). 2-NP-AOZ can be used to determination of the AOZ residues. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
2-NP-AOZ (Standard) | ≥98% | 2-NP-AOZ (Standard) is the analytical standard of 2-NP-AOZ. This product is intended for research and analytical applications. 2-NP-AOZ is a 2-nitrophenyl derivative of AOZ (HY-W012982, a tissue-bound metabolite of the Furazolidone). 2-NP-AOZ can be used to determination of the AOZ residues. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
2-NP-AOZ | 99.94% | 2-NP-AOZ is a 2-nitrophenyl derivative of AOZ (HY-W012982, a tissue-bound metabolite of the Furazolidone). 2-NP-AOZ can be used to determination of the AOZ residues. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Cheng CC, et, al. Development and residue screening of the furazolidone metabolite, 3-amino-2-oxazolidinone (AOZ), in cultured fish by an enzyme-linked immunosorbent assay. J Agric Food Chem. 2009 Jul 8;57(13):5687-92. [Content Brief]
- [2]. Li Z, et, al. Simultaneous detection of four nitrofuran metabolites in honey by using a visualized microarray screen assay. Food Chem. 2017 Apr 15;221:1813-1821. [Content Brief]